• 29983 Citations
  • 74 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 22 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1988 2021

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health

7/1/026/30/21

Project: Research project

Neoplasms
Organized Financing
Research
Research Personnel
Clinical Trials

UCDCCC NCTN UG1 PROGRAM

Gandara, D. R.

Project: Research project

UCDCCC NCTN U10 Program

Gandara, D. R. & Valicenti, R.

National Institutes of Health

4/14/142/28/19

Project: Research project

Neoplasms
Research Personnel
Clinical Trials
Clinical Nursing Research
Biostatistics

Research Output 1978 2019

EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade

Narayanan, A., Knollmann, F. D., Walby, J. A. S., Lim, S., Gandara, D. R. & Riess, J., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Human Herpesvirus 4
Immunotherapy
Carcinoma
Lung
MPDL3280A
3 Citations (Scopus)

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J. Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D. R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., Sandler, A., Ballinger, M., Kowanetz, M. & Park, K., Jan 1 2019, In : European Journal of Cancer. 107, p. 124-132 9 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Survivors
Survival
MPDL3280A
1 Citation (Scopus)
Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Neoplasms
Mutation
2 Citations (Scopus)

American society of clinical oncology's global oncology leadership task force: Findings and actions

Hortobagyi, G. N., Pyle, D., Cazap, E. L., El Saghir, N. S., Shulman, L. N., Lyman, G. H., Schnipper, L. E., Adebamowo, C. A., Gandara, D. R., Vose, J., Wong, S. L. & Yu, P., Mar 1 2018, In : Journal of global oncology. 2018, 4

Research output: Contribution to journalArticle

Medical Oncology
Advisory Committees
South America
Quality of Health Care
Focus Groups
2 Citations (Scopus)

A model of overall survival predicts treatment outcomes with atezolizumab versus chemotherapy in non–small cell lung cancer based on early tumor kinetics

Claret, L., Jin, J. Y., Ferte, C., Winter, H., Girish, S., Stroh, M., He, P., Ballinger, M., Sandler, A., Joshi, A., Rittmeyer, A., Gandara, D. R., Soria, J. C. & Bruno, R., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3292-3298 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Drug Therapy
Survival
docetaxel
Neoplasms